Jean F. Voltaire

Array ( [id] => 8834616 [patent_doc_number] => 08450372 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Formulations of suberoylanilide hydroxamic acid and methods for producing same' [patent_app_type] => utility [patent_app_number] => 12/686843 [patent_app_country] => US [patent_app_date] => 2010-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26543 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12686843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519031 [patent_doc_number] => 20100203048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE USE OF THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/686231 [patent_app_country] => US [patent_app_date] => 2010-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16540 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203048.pdf [firstpage_image] =>[orig_patent_app_number] => 12686231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628415 [patent_doc_number] => 20100173013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'TREATMENT OF NEOPLASTIC DISORDERS USING COMBINATION THERAPIES' [patent_app_type] => utility [patent_app_number] => 12/684053 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 32354 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173013.pdf [firstpage_image] =>[orig_patent_app_number] => 12684053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6455934 [patent_doc_number] => 20100105741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'ADMINISTRATION OF PYRIDINEDICARBOXYLIC ACID COMPOUNDS FOR STIMULATING OR INDUCING THE GROWTH OF HUMAN KERATINOUS FIBERS AND/OR ARRESTING THEIR LOSS' [patent_app_type] => utility [patent_app_number] => 12/650777 [patent_app_country] => US [patent_app_date] => 2009-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6283 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105741.pdf [firstpage_image] =>[orig_patent_app_number] => 12650777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768065 [patent_doc_number] => 20120035200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'GRISEOFULVIN ANALOGUES FOR THE TREATMENT OF CANCER BY INHIBITION OF CENTROSOMAL CLUSTERING' [patent_app_type] => utility [patent_app_number] => 13/141231 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16375 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035200.pdf [firstpage_image] =>[orig_patent_app_number] => 13141231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9524144 [patent_doc_number] => 08748408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Methods of treatment of mitochondrial disorders' [patent_app_type] => utility [patent_app_number] => 12/643920 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5467 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12643920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231543 [patent_doc_number] => 20100184702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Selective High-Affinity Polydentate Ligands and Methods of Making Such' [patent_app_type] => utility [patent_app_number] => 12/642684 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 38226 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184702.pdf [firstpage_image] =>[orig_patent_app_number] => 12642684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431354 [patent_doc_number] => 20100152130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'TREATMENT OF CANCER WITH GLUTAMINE' [patent_app_type] => utility [patent_app_number] => 12/631895 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 24575 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152130.pdf [firstpage_image] =>[orig_patent_app_number] => 12631895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296249 [patent_doc_number] => 20100160401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => '4-PHENYLIMIDAZOLE-2-THIONE TYROSINASE INHIBITORS AND TREATMENT OR PREVENTION OF PIGMENTARY DISORDERS THEREWITH' [patent_app_type] => utility [patent_app_number] => 12/631450 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3298 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160401.pdf [firstpage_image] =>[orig_patent_app_number] => 12631450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575452 [patent_doc_number] => 20100273740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Phospholipids for the Treatment of Infection by Togaviruses, Herpes Viruses and Coronaviruses' [patent_app_type] => utility [patent_app_number] => 12/623612 [patent_app_country] => US [patent_app_date] => 2009-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24758 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273740.pdf [firstpage_image] =>[orig_patent_app_number] => 12623612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302335 [patent_doc_number] => 20100068206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR TREATMENT OF MANTLE CELL LYMPHOMAS' [patent_app_type] => utility [patent_app_number] => 12/621502 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12166 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068206.pdf [firstpage_image] =>[orig_patent_app_number] => 12621502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574622 [patent_doc_number] => 20100129363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'METHODS AND COMPOSITIONS USING PDE4 INHIBITORS FOR THE TREATMENT AND MANAGEMENT OF CANCERS' [patent_app_type] => utility [patent_app_number] => 12/621445 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21085 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129363.pdf [firstpage_image] =>[orig_patent_app_number] => 12621445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427649 [patent_doc_number] => 08703724 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Low-viscous anthracycline formulation' [patent_app_type] => utility [patent_app_number] => 12/619161 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2611 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12619161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511500 [patent_doc_number] => 20110257210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX' [patent_app_type] => utility [patent_app_number] => 13/129186 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7503 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257210.pdf [firstpage_image] =>[orig_patent_app_number] => 13129186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6605923 [patent_doc_number] => 20100063137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Cytotoxin Compound And Method of Isolation' [patent_app_type] => utility [patent_app_number] => 12/618461 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 5691 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063137.pdf [firstpage_image] =>[orig_patent_app_number] => 12618461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244932 [patent_doc_number] => 08202860 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)' [patent_app_type] => utility [patent_app_number] => 12/608748 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4553 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202860.pdf [firstpage_image] =>[orig_patent_app_number] => 12608748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594592 [patent_doc_number] => 20100048518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent' [patent_app_type] => utility [patent_app_number] => 12/606950 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2783 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048518.pdf [firstpage_image] =>[orig_patent_app_number] => 12606950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469900 [patent_doc_number] => 08299078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin' [patent_app_type] => utility [patent_app_number] => 12/603117 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 3506 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12603117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351384 [patent_doc_number] => 20100331280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Modulation of the Phospholipase A2 Pathway as a Therapeutic' [patent_app_type] => utility [patent_app_number] => 12/582229 [patent_app_country] => US [patent_app_date] => 2009-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16020 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331280.pdf [firstpage_image] =>[orig_patent_app_number] => 12582229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6606088 [patent_doc_number] => 20100063145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'ACID CONTAINING OXALIPLATIN FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/581514 [patent_app_country] => US [patent_app_date] => 2009-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10762 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063145.pdf [firstpage_image] =>[orig_patent_app_number] => 12581514 [rel_patent_id] =>[rel_patent_doc_number] =>)